Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Application and validation of a diagnostic algorithm for the atherogenic apoB dyslipoproteinemias: ApoB dyslipoproteinemias in a Dutch population-based study.

Holewijn S, Sniderman AD, den Heijer M, Swinkels DW, Stalenhoef AF, de Graaf J.

Eur J Clin Invest. 2011 Apr;41(4):423-33. doi: 10.1111/j.1365-2362.2010.02426.x. Epub 2010 Dec 3.

PMID:
21128932
2.

Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.

Sniderman A, Couture P, de Graaf J.

Nat Rev Endocrinol. 2010 Jun;6(6):335-46. doi: 10.1038/nrendo.2010.50. Epub 2010 Apr 27. Review.

PMID:
20421882
3.

A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.

de Graaf J, Couture P, Sniderman A.

Nat Clin Pract Endocrinol Metab. 2008 Nov;4(11):608-18. doi: 10.1038/ncpendmet0982. Epub 2008 Oct 7. Review.

PMID:
18838971
4.
5.

[The use of apolipoprotein B in clinical practice to determine the risk for atherosclerosis].

Cabezas Castro M, Liem A.

Ned Tijdschr Geneeskd. 2003 Jul 26;147(30):1445-8. Review. Dutch.

PMID:
12908345
6.

Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk.

Sniderman AD, St-Pierre AC, Cantin B, Dagenais GR, Després JP, Lamarche B.

Am J Cardiol. 2003 May 15;91(10):1173-7.

PMID:
12745098
7.

Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.

Veerkamp MJ, de Graaf J, Hendriks JC, Demacker PN, Stalenhoef AF.

Circulation. 2004 Jun 22;109(24):2980-5. Epub 2004 Jun 7.

8.
9.

Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns.

Katulanda GW, Katulanda P, Adler AI, Peiris SR, Draisey I, Wijeratne S, Sheriff R, Matthews DR, Shine B.

Ann Clin Biochem. 2010 Jan;47(Pt 1):29-34. doi: 10.1258/acb.2009.009080. Epub 2009 Dec 1.

PMID:
19952033
10.

Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care.

Bestehorn K, Smolka W, Pittrow D, Schulte H, Assmann G.

Curr Med Res Opin. 2010 Dec;26(12):2833-9. doi: 10.1185/03007995.2010.532088. Epub 2010 Nov 8.

PMID:
21058895
11.

Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.

Tsimikas S, Kiechl S, Willeit J, Mayr M, Miller ER, Kronenberg F, Xu Q, Bergmark C, Weger S, Oberhollenzer F, Witztum JL.

J Am Coll Cardiol. 2006 Jun 6;47(11):2219-28. Epub 2006 May 15.

12.

Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk.

Holewijn S, den Heijer M, Swinkels DW, Stalenhoef AF, de Graaf J.

J Intern Med. 2010 Dec;268(6):567-77. doi: 10.1111/j.1365-2796.2010.02277.x.

13.

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes.

Taskinen MR, Barter PJ, Ehnholm C, Sullivan DR, Mann K, Simes J, Best JD, Hamwood S, Keech AC; FIELD study investigators.

Diabetologia. 2010 Sep;53(9):1846-55. doi: 10.1007/s00125-010-1806-9. Epub 2010 Jun 6.

PMID:
20526762
14.

Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.

Juonala M, Viikari JS, Kähönen M, Solakivi T, Helenius H, Jula A, Marniemi J, Taittonen L, Laitinen T, Nikkari T, Raitakari OT.

J Am Coll Cardiol. 2008 Jul 22;52(4):293-9. doi: 10.1016/j.jacc.2008.03.054.

15.

[Metabolic peculiarities of dyslipoproteinemias unrelated to high level of blood cholesterol].

Perova NV, Ozerova IN, Aleksandrovich OV, Metel'skaia VA, Shal'nova SA, Shkol'nikova MA.

Kardiologiia. 2008;48(11):42-6. Russian.

PMID:
19076079
16.

Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.

Talmud PJ, Hawe E, Miller GJ, Humphries SE.

Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1918-23.

17.

Obesity and atherogenic dyslipidemia.

Bamba V, Rader DJ.

Gastroenterology. 2007 May;132(6):2181-90. Review.

PMID:
17498511
18.

Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients.

Badiou S, Thiebaut R, Aurillac-Lavignolle V, Dabis F, Laporte F, Cristol JP, Mercie P; Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).

J Infect. 2008 Jul;57(1):47-54. doi: 10.1016/j.jinf.2008.05.007. Epub 2008 Jun 12.

PMID:
18554723
19.

Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.

El ayachi M, Mziwira M, Vincent S, Defoort C, Portugal H, Lairon D, Belahsen R.

Eur J Clin Nutr. 2005 Dec;59(12):1379-86.

PMID:
16118656
20.

Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.

Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.

Clin Ther. 2007 Aug;29(8):1671-81.

PMID:
17919548
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk